Evidence map›Paper›PMID 36106102›Full record

ArticleFrontiers in oncology2022

Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report.

Florian Ramdohr, Alice Fabarius, Bettina Maier, Daniela Bretschneider, Anna Jauch, Astrid Monecke, Klaus H Metzeler, Johannes W G Janssen, Richard F Schlenk, Sabine Kayser

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. [Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Florian RamdohrMedical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
Alice FabariusDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Bettina MaierDepartment of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
Daniela BretschneiderMedical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
Anna JauchInstitute of Human Genetics, University Heidelberg, Heidelberg, Germany.
Astrid MoneckeDepartment of Diagnostics, Institute of Pathology, University Hospital Leipzig, Leipzig, Germany.
Klaus H MetzelerMedical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
Johannes W G JanssenInstitute of Human Genetics, University Heidelberg, Heidelberg, Germany.
Richard F SchlenkDepartment of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
Sabine KayserMedical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
University Hospital Leipzig · DEHeidelberg University · DEGerman Cancer Research Center · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of the translocation t(9;22)(q34;q11), leading to the

Indexed as

atypical transcriptsBCR-ABL +chronic myedoid leukemia (CML)e6a2outcometyrosine kinase inhibitors

Identifiers

PMID36106102
PMCPMC9464917
OpenAlexW4293421070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.